Glenmark Pharmaceuticals Inc. issued a recall for some of its Potassium Chloride Extended-Release Capsules over a "failed dissolution" that may cause heart attacks.

Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The product is ...

The FDA's Drug Shortages database lists potassium chloride concentrate injection as currently in shortage, with just a few manufacturers: B. Braun Medical, Fresenius Kabi, and Hospira (which was ...

Germany’s K+S Kali has unveiled its new brand of food grade potassium chloride called KaliSel, which is billed as a cost-effective salt replacer in food. The food industry is currently operating to a ...

Drug Involved in Errors: Potassium chloride, a salt available in a host of generic formulations, including solutions, tablets and injectible forms. Indication: Low potassium levels, often as a ...

Watson plans to launch its Potassium Chloride Extended-Release product during the third quarter of 2008. The specific launch date will depend upon the timing of product validation activities and ...